Non-pharmacologic (physiologic) neuroprotection in... (2001 study) Skip to main content
Clinical Trial Ann N Y Acad Sci 2001 Canadian

Non-pharmacologic (physiologic) neuroprotection in the treatment of brain ischemia

Auer R, Ann N Y Acad Sci, 2001

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

A Canadian author reviewed five non-drug measures that might limit brain damage from ischemia, meaning reduced blood flow to the brain, and argued that they should be tested in clinical trials.

What They Found

This narrative review of five physiologic measures for brain ischemia found that hypothermia was protective in both focal and global ischemia, and that the other four measures (insulin, controlled arterial hyperoxemia, blood pressure control and magnesium) also had supporting evidence, some of it experimental. The author notes that clinical trials of drugs for ischemic stroke have had a series of disappointing negative results. Hypothermia protected even when started after the ischemia. Its benefit depends on the delay, depth and duration of cooling. Controlled arterial hyperoxemia seemed effective experimentally in reducing infarct size. Raising blood pressure improved collateral blood flow and reduced stroke size, but hemorrhage must be ruled out first. In aneurysm patients with vasospasm, minor blood pressure increases reversed temporary hemiparesis. Magnesium and insulin together were shown effective in experimental brain ischemia.

Canadian Relevance

The study is marked as having a Canadian connection.

Study Limitations

The abstract describes mostly experimental evidence and a few clinical observations rather than controlled human trials, and the author states that the five measures still need to be tested in clinical trials.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Trial
Category Neurological
Source Pubmed
PubMed ID 11462780
Year Published 2001
Journal Ann N Y Acad Sci
MeSH Terms Animals; Blood Pressure; Brain Ischemia; Humans; Hyperbaric Oxygenation; Hypoglycemic Agents; Hypothermia, Induced; Insulin; Magnesium

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology